Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) EBIT Margin (2023 - 2026)

Updated

Mereo BioPharma (MREO) reported EBIT Margin of -8021.40% for FY2025.

Analysis

Mereo BioPharma (MREO) EBIT Margin (2023 - 2026) Analysis & Trends

  • EBIT Margin has a four-year change of -7963.98 percentage points (FY2021 to FY2025).
  • According to Business Quant data, EBIT Margin came in at -284.16% in FY2023 and -57.42% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Mereo BioPharma 46.45 Mn -103.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -79,690.91%
Jun 30, 2025 -2,099.80%
Dec 31, 2023 -712.80%
Jun 30, 2023 -9.01%
API Access

Mereo BioPharma EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=MREO&period=max&api_key=YOUR_API_KEY